START FREE TRIAL

Nvidia Just Closed The Arm Chapter—Here’s What It Really Means!

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

When Nvidia Corp. (NASDAQ:NVDA) quietly sold the last of its shares in Arm Holdings Plc, it marked the end of a saga that began with a bold $40 billion takeover attempt in 2020. That deal collapsed in 2022 after intense regulatory pushback. Now, Nvidia has fully exited its remaining 1.1 million Arm shares, worth roughly $140 million. On the surface, this looks like simple portfolio cleanup. But the timing matters. Nvidia is generating record cash flows, guiding to $65 billion in quarterly revenue, and forecasting $500 billion in Blackwell and Rubin revenue through 2026. At the same time, AI infrastructure spending is accelerating globally. So this sale is not just about closing a chapter. It reflects capital allocation priorities, reinforces Arm’s independence narrative, and sends a signal about how power is shifting inside the AI semiconductor ecosystem.

Strategic Closure Of The Arm Saga

Nvidia’s relationship with Arm has been complicated from the start. In 2020, Nvidia agreed to acquire Arm from SoftBank Group Corp. in what would have been the…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Is SpaceX Asking $1.75 Trillion For A Company Truly Worth NO MORE THAN $780 Billion?

The largest IPO in history just launched its roadshow....

Related Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Broadcom Said 3 Words That Killed The Narrative: “WE ARE CHIPS ONLY!”A

Let's do the math quickly. Broadcom (NASDAQ:AVGO) just reported $10.8...

Berkshire Paid BELOW Market for Alphabet & the Stock Fell; Who’s WRONG?

Let's start with the weird part. On Monday, Alphabet (NASDAQ:...
spot_img

Related Articles

Popular Categories

spot_imgspot_img